Portage Biotech- Plan to Replace 1 Patient in Adport-601 Trial Who Withdrew Prior to Dose Limiting Toxicity Assessment for Unrelated Adverse Event
Portage Biotech計劃在Adport-601試驗中替換一名患者,該患者在無關不良事件的劑量限制毒性評估前退出了試驗。
Portage Biotech- Plan to Replace 1 Patient in Adport-601 Trial Who Withdrew Prior to Dose Limiting Toxicity Assessment for Unrelated Adverse Event
Portage Biotech計劃在Adport-601試驗中替換一名患者,該患者在無關不良事件的劑量限制毒性評估前退出了試驗。
譯文內容由第三人軟體翻譯。